Patient Services Vie For Bigger Share Of AIDS Funds

WASHINGTON-In the early 1980s, the lonely voices seeking funds for AIDS research were barely audible amid the din from the biomedical community as a whole. Over the past eight years, however, with the public also demanding that science step up its battle against the devastating-disease, the United States government has poured $5.5 billion into the AIDS epidemic, including $2.1 billion in the current year ending September 30. So far, about 40% of that total, nearly $2.2 billion, has been spent on

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

However, while the investment in basic research has added greatly to the store of knowledge about the AIDS virus, it has not yet led to an effective treatment: much less a cure. At the same time, more people are getting sick and living longer with the disease. And their plight threatens to control the hearts and. purse strings of society and drown out those who advocate the cause of science.

"AIDS is now a treatable disease," says Reed V. Tuckson, District of Columbia commissioner of health. "The implications of that are tremendous. Few health care systems are equipped to handle what's coming; nor is there much planning going on." Given the nation's limited resources, he adds, efforts to cope with the problem are "going to make Americans look like barbarians."

For scientists, the overwhelming need for care forebodes a potential squeeze on scarce resources. "We have a national consensus on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Elizabeth Pennisi

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours